Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regenxbio Inc. (RGNX)  
$16.19 0.13 (0.81%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 43,990,000
Market Cap: 712.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $12.17 - $24.61
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 57,878 165,115 165,115 195,533
Total Sell Value $1,217,382 $3,085,988 $3,085,988 $4,069,195
Total People Sold 2 2 2 3
Total Sell Transactions 4 7 7 14
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 404
  Page 1 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mills Kenneth T. President and CEO   •       •      –    2024-04-15 4 AS $18.19 $272,871 D/D (15,000) 408,035 -10%     
   Mills Kenneth T. President and CEO   •       •      –    2024-04-15 4 OE $3.76 $56,400 D/D 15,000 423,035     -
   Vasista Vittal Chief Financial Officer   •       –      –    2024-03-19 4 OE $3.76 $75,354 D/D 20,041 246,534     -
   Mills Kenneth T. President and CEO   •       •      –    2024-03-14 4 AS $21.86 $327,942 D/D (15,000) 408,035 -26%     
   Mills Kenneth T. President and CEO   •       •      –    2024-03-14 4 OE $3.76 $56,400 D/D 15,000 423,035     -
   Pakola Steve Chief Medical Officer   •       –      –    2024-03-05 4 AS $28.36 $365,220 D/D (12,878) 107,192 -34%     
   Pakola Steve Chief Medical Officer   •       –      –    2024-03-05 4 OE $22.25 $286,536 D/D 12,878 120,070     -
   Mills Kenneth T. President and CEO   •       •      –    2024-02-14 4 AS $16.47 $251,349 D/D (15,000) 408,035 -4%     
   Mills Kenneth T. President and CEO   •       •      –    2024-02-14 4 OE $3.76 $56,400 D/D 15,000 423,035     -
   Mills Kenneth T. President and CEO   •       •      –    2024-01-16 4 AS $15.18 $682,992 D/D (45,000) 408,035 6%     
   Mills Kenneth T. President and CEO   •       •      –    2024-01-16 4 OE $3.76 $169,200 D/D 45,000 453,035     -
   Pakola Steve Chief Medical Officer   •       –      –    2024-01-03 4 AS $17.39 $299,789 D/D (17,237) 107,192 -6%     
   Pakola Steve Chief Medical Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 32,051 124,429     -
   Pakola Steve Chief Medical Officer   •       –      –    2024-01-02 4 D $17.95 $186,411 D/D (10,385) 92,378     -
   Mills Kenneth T. President and CEO   •       •      –    2024-01-02 4 A $0.00 $0 D/D 64,103 408,035     -
   Mills Kenneth T. President and CEO   •       •      –    2024-01-02 4 D $17.95 $203,858 D/D (11,357) 343,932     -
   Simpson Curran Chief Oper. & Tech. Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 38,462 123,327     -
   Simpson Curran Chief Oper. & Tech. Officer   •       –      –    2024-01-02 4 D $17.95 $145,754 D/D (8,120) 84,865     -
   Christmas Patrick J. Chief Legal Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 34,615 115,759     -
   Christmas Patrick J. Chief Legal Officer   •       –      –    2024-01-02 4 D $17.95 $141,679 D/D (7,893) 81,144     -
   Vasista Vittal Chief Financial Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 16,026 226,493     -
   Vasista Vittal Chief Financial Officer   •       –      –    2024-01-02 4 D $17.95 $81,385 D/D (4,534) 210,467     -
   Danos Olivier Chief Scientific Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 38,462 124,853     -
   Danos Olivier Chief Scientific Officer   •       –      –    2024-01-02 4 D $17.95 $150,960 D/D (8,410) 86,391     -
   Mills Kenneth T. President and CEO   •       •      –    2023-12-19 4 AS $19.69 $885,825 D/D (45,000) 355,289 -17%     
  404 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us